Back to Point72 Asset Management, L.P. Point72 Asset Management, L.P.

AVTXAVTX
4 quarters

Position history for Point72 Asset Management, L.P.Point72 Asset Management, L.P.'s holdings in AVALO THERAPEUTICS INC

Yes. Point72 Asset Management holds 2,387,026 shares of AVTX (Avalo Therapeutics), worth $44.1M, as of its Q2 2026 13F filing. It increased the position by 1,470,884 shares (+160.6%) from Q1 2026. Point72 Asset Management has held AVTX since Q3 2025, across 4 quarterly 13F filings.

Current Value

$44.1M

Current Shares

2.4M

Total Value Change

+$30.7M

Total Shares Change

+1.3M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
2.4M
+160.6%
$44.1M0.0%$18.48
47
2026-Q1
Increased
916,142
+46.0%
$13.7M0.0%$18.85
38
2025-Q4
Decreased
627,502
-40.5%
$11.4M0.0%$17.81
0
2025-Q3
New
1.1M
-
$13.4M0.0%$13.02
39

Other major holders of AVTX: FMR LLC, BlackRock, Inc., STATE STREET CORP, FARALLON CAPITAL MANAGEMENT, L.L.C., Avoro Capital Advisors LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used